Transforming growth factor-beta (TGF-beta) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no clearly defined role in TGF-beta signaling. Cardiac endothelial cells that undergo epithelial-mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial cells conferred transformation in response to TGF-beta2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-beta signaling.
Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart.
Reference
Brown, C B, et al. “Requirement of Type III TGF-Beta Receptor for Endocardial Cell Transformation in the Heart”. Science, vol. 283, no. 5410, Mar. 1999, pp. 2080-2.
Abstract